Pirfenidone Tablets

Pirfenidone Tablets

Categories : Hematology

Product Packaging : 10 / 30 tablets

Product Composition : 200 mg

Pirfenidone Tablets are a therapeutic oral formulation used to manage idiopathic pulmonary fibrosis (IPF) and slow lung tissue scarring. The tablets help reduce inflammation, improve pulmonary function, and support better respiratory health.

Genliva Wellness LLP is a leading Pirfenidone Tablets manufacturer in India, providing premium-quality, GMP and ISO-certified tablets. The company is also a Pirfenidone Tablets and contract manufacturer, catering to hospitals, clinics, and international pharma distributors with reliable and safe formulations.

These tablets are widely used in pulmonary care centers to ensure consistent and effective fibrosis management.

Send Message

Pirfenidone Tablets are a therapeutic oral formulation used to manage idiopathic pulmonary fibrosis (IPF) and slow lung tissue scarring. The tablets help reduce inflammation, improve pulmonary function, and support better respiratory health.

Genliva Wellness LLP is a leading Pirfenidone Tablets manufacturer in India, providing premium-quality, GMP and ISO-certified tablets. The company is also a Pirfenidone Tablets and contract manufacturer, catering to hospitals, clinics, and international pharma distributors with reliable and safe formulations.

These tablets are widely used in pulmonary care centers to ensure consistent and effective fibrosis management.

  • High-quality Pirfenidone Tablets manufactured in India
  • Supports slowing fibrosis progression and reducing lung inflammation
  • Available in dosage strengths of 200 mg, 267 mg, 300 mg
  • Manufactured using validated processes with pure APIs
  • Suitable for bulk orders, private labeling, and global distribution
  • Compliant with GMP, ISO standards, and quality certifications
  • Designed for hospital, outpatient, and institutional supply
  • Flexible for contract manufacturing and third-party production

Pirfenidone Tablets are indicated for:

  • Managing idiopathic pulmonary fibrosis (IPF)
  • Reducing lung tissue scarring and inflammation
  • Slowing disease progression in chronic pulmonary disorders
  • Supporting better lung capacity and breathing efficiency
  • Adjunct therapy in progressive fibrotic lung conditions
  • Improving overall quality of life in lung disease patients
  • Oral tablet ensures precise daily dosing
  • Convenient for long-term therapy at home or in clinics
  • Stable formulation for international shipping and storage
  • Compatible with blister, bottle, or bulk packaging
  • Economical for hospital and distributor procurement

whatsapp-app